DRUG NEWS: New nonnarcotic eases chronic pain

June 2005 
Volume 35  Number 6
Pages 30 - 30
  PDF Version Available!

© 2005 Lippincott Williams & Wilkins, Inc. Volume 35(6)             June 2005             p 30 New nonnarcotic eases chronic pain [DRUG NEWS: INTRATHECAL ANALGESIA]

For the first time in over 20 years, a new intrathecal analgesic has won FDA approval. Ziconotide intrathecal infusion (PRIALT) is indicated for patients with severe chronic pain who can't tolerate or haven't responded to other treatments, including systemic analgesics, adjunctive therapies, or intrathecal morphine. Classified as a nonopioid analgesic known as an N-type calcium channel blocker, PRIALT isn't addictive. It's the synthetic equivalent of a pain-killing chemical found in certain sea snails.

When tested in three clinical trials involving more than 1,200 patients whose severe chronic pain wasn't adequately managed with other analgesics, PRIALT proved effective and safe. Common adverse reactions included ...

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!

1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.

Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.

Featured Jobs

Benefits of Membership

FREE E-Newsletters
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues

Join our CESaver program to earn up to 100 contact hours for only $34.95
Register Now

Lippincott's NursingCenter.com
Explore a world of online resources

Become a Member